Fig. 4
From: Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV
Anxiety-related behavior* time course in SIV infected rhesus macaque receiving aprepitant at 125 mg/day or placebo. *Anxiety-related behavior was calculated based on the following parameters: body shake, hypervigilant scanning, self-licking and self-grooming, scratching, unresponsive inactivity and yawning. Results are presented as mean ± SD for each group of animals (n = 4/group)